Call for abstracts for ESMO Immuno-Oncology 2024 Congress
European Society for Medical Oncology (ESMO) shared on LinkedIn:
“ESMOImmuno24!
Don’t miss your chance for global recognition.
Present your research to an international audience of top-tier scientists, clinicians, and industry experts.
Deadline: 1 October 2024
Networking: Connect with leading researchers, potential collaborators, and industry pioneers.
Professional Growth: Gain visibility and enhance your profile within the scientific community.
Publication Opportunity: Accepted abstracts, including late-breaking abstracts, will be published online only in ESMO IOTECH.
We welcome submissions on a wide range of Immunooncology topics, including:
Biomarker Development Cell therapy/Immune engineering Clinical Practice Therapeutic development tumour biology and tumour microenvironment Miscellaneous.”
Additional information.
Proceed to video attached to the post.
Source: ESMO/LinkedIn